These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9653014)

  • 1. Candida onychomycosis in HIV infection.
    Tosti A; Piraccini BM; Lorenzi S; D'Antuono A
    Eur J Dermatol; 1998; 8(3):173-4. PubMed ID: 9653014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
    Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR
    J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases.
    Tosti A; Piraccini BM; Lorenzi S
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):217-24. PubMed ID: 10642676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terbinafine in the treatment of onychomycosis: a review of its efficacy in high-risk populations and in patients with nondermatophyte infections.
    Cribier BJ; Bakshi R
    Br J Dermatol; 2004 Mar; 150(3):414-20. PubMed ID: 15030322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune polyglandular syndrome (APS) type 1 and candida onychomycosis.
    Manz B; Scholz GH; Willgerodt H; Haustein UF; Nenoff P
    Eur J Dermatol; 2002; 12(3):283-6. PubMed ID: 11978574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onychomycosis due to Scopulariopsis brevicaulis: clinical features and response to systemic antifungals.
    Tosti A; Piraccini BM; Stinchi C; Lorenzi S
    Br J Dermatol; 1996 Nov; 135(5):799-802. PubMed ID: 8977686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newer systemic antifungal drugs for the treatment of onychomycosis.
    Chiritescu MM; Chiritescu ME; Scher RK
    Clin Podiatr Med Surg; 1996 Oct; 13(4):741-58. PubMed ID: 8902341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis.
    Gupta AK; Ryder JE; Johnson AM
    Br J Dermatol; 2004 Mar; 150(3):537-44. PubMed ID: 15030339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance of Candida species to antifungal agents used in the treatment of onychomycosis: a review of current problems.
    Evans EG
    Br J Dermatol; 1999 Nov; 141 Suppl 56():33-5. PubMed ID: 10730912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Itraconazole in the treatment of superficial cutaneous and mucosal Candida infections.
    Del Rosso JQ; Zellis S; Gupta AK
    J Am Osteopath Assoc; 1998 Sep; 98(9):497-502. PubMed ID: 9785744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of amorolfine 5% solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis.
    Rigopoulos D; Katoulis AC; Ioannides D; Georgala S; Kalogeromitros D; Bolbasis I; Karistinou A; Christofidou E; Polydorou D; Balkou P; Fragouli E; Katsambas AD
    Br J Dermatol; 2003 Jul; 149(1):151-6. PubMed ID: 12890209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot evaluation of pulse itraconazole vs. terbinafine for treatment of Candida toenail onychomycosis.
    Warshaw EM; Nelson D; Carver SM; Zielke GR; Webster N; Lederle FA; Fett DD
    Int J Dermatol; 2005 Sep; 44(9):785-8. PubMed ID: 16135154
    [No Abstract]   [Full Text] [Related]  

  • 13. Treating onychomycosis.
    Rodgers P; Bassler M
    Am Fam Physician; 2001 Feb; 63(4):663-72, 677-8. PubMed ID: 11237081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and mycological responses to fluconazole and fluconazole MIC in oropharyngeal candidiasis in HIV-infected patients.
    Bussaratid V; Tansupasawasdikul S; Simpson A; Pitisuttithum P; Phonrat B; Howe P; White NJ
    J Med Assoc Thai; 2002 Jul; 85(7):757-64. PubMed ID: 12296406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
    Gupta AK; Lynde CW; Konnikov N
    J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of fluconazole and urea in a nail lacquer for treating onychomycosis.
    Baran R; Coquard F
    J Dermatolog Treat; 2005 Feb; 16(1):52-5. PubMed ID: 15897169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Etiopathogenesis, clinical picture and diagnosis of onychomycoses].
    Tasić S; Stojanović S; Poljacki M
    Med Pregl; 2001; 54(1-2):45-51. PubMed ID: 11432322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK; Konnikov N; Lynde CW
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fluconazole and treatment of onychomycosis. About 86 cases].
    El Euch D; Bouassida S; Kourda M; Ezzine N; Denguezli M; Mokhtar I; Doss N; Turki H; Ridha Kamoun M; Nouira R; Ben Osman Dhahril A
    Tunis Med; 2006 Oct; 84(10):640-3. PubMed ID: 17193857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of fluconazole for the treatment of onychomycosis.
    Brown SJ
    Ann Pharmacother; 2009 Oct; 43(10):1684-91. PubMed ID: 19776299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.